Family Health International Joins Tb Trials Consortium in Global Quest to Improve Tb Treatment
U.S. Newswire › March 24, 2010
Linked as:
Summary
Faster, Less Toxic Drug Regimens Would Increase TB Cure Rates
RESEARCH TRIANGLE PARK, N.C., March 24 /PRNewswire-USNewswire/ -- Family Health International (FHI), a nonprofit global health and development organization working to improve the lives of the world's most vulnerable people, recently joined the Tuberculosis Trials Consortium (TBTC), an international body that researches new TB drugs and treatment strategies. The consortium is funded by the US Centers for Disease Control and Prevention (CDC). As part of the consortium, FHI is partnering with Duke University Medical Center to conduct clinical trials that aim to reduce the duration of TB treatment and lessen the side effects of TB drugs.See the full content of this document
Extract
Family Health International Joins Tb Trials Consortium in Global Quest to Improve Tb Treatment
The work of the TBTC is advancing the development of improved TB treatment, which has remained largely unchanged for 50 years. First- line TB treatment involves taking four pills once a da...
See the full content of this document
Sponsored links
